Acute Exacerbation of Liver Disease Induced by Pegylated Interferon Alpha 2 a Treatment for Chronic Hepatitis C


A 66-year-old female was referred to a local clinic for the treatment of chronic hepatitis C. Her family physician started the administration of Peg-IFN alpha2a in combination with ribavirin in September, 2008. Three months after the commencement of the therapy, alopecia was noted, and it gradually worsened. She also complained of general fatigue. Since her… (More)

2 Figures and Tables


  • Presentations referencing similar topics